Intravenous immunoglobulin for ANCA‐associated systemic vasculitis with persistent disease activity

Intravenous immunoglobulin (IVIg) is a potential alternative treatment for anti‐neutrophil cytoplasm antibody (ANCA)‐associated systemic vasculitis (AASV) with less toxicity than conventional immunosuppressive agents. This randomized, placebo‐controlled trial aimed to investigate the efficacy of a s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	QJM : An International Journal of Medicine 2000-07, Vol.93 (7), p.433-439
Hauptverfasser:	Jayne, D.R.W., Chapel, H., Adu, D., Misbah, S., O'Donoghue, D., Scott, D., Lockwood, C.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Antineutrophil Cytoplasmic - blood Antibodies, Antineutrophil Cytoplasmic - immunology Biological and medical sciences C-Reactive Protein - analysis Combined Modality Therapy Creatinine - blood Double-Blind Method Female Granulomatosis with Polyangiitis - immunology Granulomatosis with Polyangiitis - therapy Humans Immunoglobulins, Intravenous - therapeutic use Immunopathology Immunosuppressive Agents - therapeutic use Immunotherapy (general aspects) Liver Function Tests Male Medical sciences Middle Aged Treatment Outcome Vasculitis - immunology Vasculitis - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!